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Introduction
Hypoxic hepatitis (HH) is a frequent cause of acute hepa-
tocellular damage in critically ill patients associated with
high mortality. Indocyanine green, a medical dye, is
removed solely by the liver without entering enterohepatic
circulation. Therefore its plasma disappearance rate (ICG-
PDR) is an effective clinical tool for assessment of liver
function in acute and chronic hepatic disease.
Objectives
Aim of this study was to evaluate the prognostic impact of
ICG-PDR in comparison to laboratory parameters and
established scores in critically ill patients with HH and
other liver disease entities.
Methods
The impact of ICG-PDR was prospectively evaluated in
119 critically ill patients with different liver disease entities
(HH: n = 52, cirrhosis: n = 35, acute liver failure (ALF):
n = 10, control group without signs of acute liver injury,
viral or drug induced hepatitis or cirrhosis: n = 22). Plasma
disappearance rate of ICG was measured non-invasively by
using a finger pulse densitometry system.
Results
ICG-PDR on admission was significantly lower in
patients with liver diseases (HH, liver cirrhosis, ALF)
than in the control group without hepatic impairment
(median 5.7%/min, IQR 3.8-7.9%/min vs. 20.7%/min, IQR
14.1-25.4%/min; p < 0.001).
ICG-PDR predicted 28-day mortality independently of
SOFA score and serum lactate in patients with underlying
liver disease (HR 1.27, 95%CI 1.10-1.45; p < 0.005).
AUROC of ICG-PDR predicting 28-day mortality in
patients with HH was significantly higher than AUROC of
SOFA, arterial serum lactate, INR and AST 48 hours after
admission (p < 0.05). ICG-PDR increased significantly in
28-day survivors over course of time (p < 0.001). 28-day
survivors could be identified using a cut-off ICG-PDR ≥
9.0 %/min 48 hours after admission with sensitivity of 77%
and specificity 100%.
Conclusion
Diagnostic test accuracy of ICG-PDR was superior to
standard liver function parameters and well established
scoring systems in patients with HH. Therefore ICG-
PDR is a feasible non-invasive tool for early risk stratifi-
cation in patients with HH.
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